SLC5A5 and breast carcinoma: We and others have reported that RAC1 signaling potentiates the TSH-induced transcription of the NIS (SLC5A5) gene in non-transformed thyroid cells [24], and also in MCF7 breast cancer cells, in this case through the activation of p38 MAPK signaling [59].